Literature DB >> 19222092

Psychological evaluation and follow-up in liver transplantation.

Josephine-G Morana1.   

Abstract

An increasingly number of transplant centers have integrated a psychological assessment within their protocol for evaluation of patients being considered for transplantation. This paper highlights the psychological criteria for inclusion or exclusion for listing, briefly discusses the psychological dynamics of patients, and addresses possible psychotherapy and pharmacological therapy, before and after transplant.

Entities:  

Mesh:

Year:  2009        PMID: 19222092      PMCID: PMC2653437          DOI: 10.3748/wjg.15.694

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  2 in total

1.  Psychological evolution and assessment in patients undergoing orthotopic heart transplantation.

Authors:  J M Triffaux; J Wauthy; J Bertrand; R Limet; A Albert; M Ansseau
Journal:  Eur Psychiatry       Date:  2001-04       Impact factor: 5.361

2.  Liver transplantation for alcoholic liver disease: a survey of transplantation programs in the United States.

Authors:  J E Everhart; T P Beresford
Journal:  Liver Transpl Surg       Date:  1997-05
  2 in total
  3 in total

1.  Psychiatric Comorbidity, Health-Related Quality of Life, and Mental Health Service Utilization Among Patients Awaiting Liver Transplant.

Authors:  Rebecca M Saracino; Devika R Jutagir; Amy Cunningham; Kelly A Foran-Tuller; Mary A Driscoll; William H Sledge; Sukru H Emre; Dwain C Fehon
Journal:  J Pain Symptom Manage       Date:  2018-03-08       Impact factor: 3.612

2.  Liver transplantation for alcoholic liver disease.

Authors:  Vibha Varma; Kerry Webb; Darius F Mirza
Journal:  World J Gastroenterol       Date:  2010-09-21       Impact factor: 5.742

3.  Social support for patients undergoing liver transplantation in a Public University Hospital.

Authors:  Clerison Stelvio Garcia; Agnaldo Soares Lima; Ehideé Isabel Gómez La-Rotta; Ilka de Fátima Santana Ferreira Boin
Journal:  Health Qual Life Outcomes       Date:  2018-02-17       Impact factor: 3.186

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.